Ling‐Pei Ho - Concepedia

Author

Ling‐Pei Ho

University of Oxford ORCID

Also Known As

A Gupta, A Hingorani, A Mcmichael, Anastasia Fries, E Denneny, Ho, L-P, Ho, Ling-Pei, James D Chalmers, L HO, L Ho

246

Publications

13.9K

Citations

H-Index

139

Concepts

All Affiliations

University of Oxford MRC Human Immunology Unit Oxford University Hospitals NHS Trust University of Edinburgh Imperial College London

About

Ling‐Pei Ho is an author at University of Oxford specializing in medicine, immunology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	38	3K
2	Allergy	10	10	830
3	Public Health	9	9	456
4	Cell Biology	6	6	452
5	Health Sciences	2	3	139

Ling‐Pei Ho

Publications

11.1K

Citations

H-Index

Page 1

	Year	Citations
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 Yanchun Peng, Alexander J. Mentzer, Guihai Liu, Nature Immunology	2020	1.4K
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study Rachael A Evans, Hamish McAuley, Ewen M. Harrison, The Lancet Respiratory Medicine	2021	636
Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge Betty Raman, Mark Philip Cassar, Elizabeth M. Tunnicliffe, EClinicalMedicine	2021	607
MAIT cells are activated during human viral infections Bonnie van Wilgenburg, Iris Scherwitzl, Edward Hutchinson, Nature Communications	2016	509
Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences Fernando O. Martínez, Laura Helming, Ronny Milde, Blood	2013	482
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial Phillip Monk, Richard Marsden, Victoria Tear, The Lancet Respiratory Medicine Sars-cov-2 InfectionCovid-19 PandemicImmunologyAntiviral TherapyRespiratory Infection	2020	448
Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease Yan Zhao, Ling Qin, Ping Zhang, JCI Insight	2020	421
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Rachael A Evans, Olivia C. Leavy, Matthew Richardson, The Lancet Respiratory Medicine	2022	407
Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis JR Dorin, Gerry McLachlan, Hazel Davidson‐Smith, Gene Therapy Gene TherapiesTranslational MedicineFibrosisAllergyInflammatory Lung Disease	1997	321
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity David Ahern, Zhichao Ai, Mark Ainsworth, Cell	2022	319

Page 1